Learn About Chronic Inflammatory Demyelinating Polyneuropathy
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a disorder that involves nerve swelling and irritation (inflammation) that leads to a loss of strength or sensation.
Chronic inflammatory demyelinating polyradiculoneuropathy; Polyneuropathy - chronic inflammatory; CIDP; Chronic inflammatory polyneuropathy; Guillain-Barré - CIDP
CIDP is one cause of damage to nerves outside the brain or spinal cord (peripheral neuropathy). Polyneuropathy means several nerves are involved. CIDP often affects both sides of the body.
CIDP is caused by an abnormal immune response. CIDP occurs when the immune system attacks the myelin cover of the nerves. For this reason, CIDP is thought to be an autoimmune disease.
Health care providers also consider CIDP as the chronic form of Guillain-Barré syndrome.
The specific triggers of CIDP vary. In many cases, the cause cannot be identified.
CIDP may occur with other conditions, such as:
- Chronic hepatitis
- Diabetes
- Infection with the bacterium Campylobacter jejuni
- HIV/AIDS
- Immune system disorders due to cancer
- Inflammatory bowel disease
- Systemic lupus erythematosus
- Cancer of the lymph system
- Overactive thyroid
- Side effects of medicines to treat cancer or HIV
Symptoms include any of the following:
- Problems walking due to weakness or lack of feeling in the feet
- Trouble using the arms and hands or legs and feet due to weakness
- Sensation changes, such as numbness or decreased sensation, pain, burning, tingling, or other abnormal sensations (usually affects the feet first, then the arms and hands)
Other symptoms that can occur with CIDP include:
- Abnormal or uncoordinated movement
- Problems breathing
- Fatigue
- Hoarseness or changing voice or slurred speech
The goal of treatment is to reverse the attack on the nerves. In some cases, nerves can heal and their function can be restored. In other cases, nerves are badly damaged and cannot heal, so treatment is aimed at preventing the disease from getting worse.
Which treatment is given depends on how severe the symptoms are, among other things. The most aggressive treatment is only given if you have difficulty walking, breathing, or if symptoms don't allow you to care for yourself or work.
Treatments may include:
- Corticosteroids to help reduce inflammation and relieve symptoms
- Other medicines that suppress the immune system (for some severe cases)
- Plasmapheresis or plasma exchange to remove antibodies from the blood
- Intravenous immune globulin (IVIg), which involves injecting antibodies into the bloodstream to reduce the effect of the antibodies that are causing the problem
Regents Of The University Of California
Tahseen Mozaffar is a Neurologist and an Orthopedics provider in Orange, California. Dr. Mozaffar and is rated as a Distinguished provider by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. His top areas of expertise are Inclusion Body Myositis, Pompe Disease, Myositis, Myasthenia Gravis, and Thymectomy.
Neurology And Pain Specialty Center
Kenneth Martinez is a Neurologist in Aliso Viejo, California. Dr. Martinez and is rated as an Experienced provider by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. His top areas of expertise are Chronic Demyelinizing Neuropathy with IgM Monoclonal, Parkinson's Disease, Hydrocephalus, and Congenital Cardiovascular Shunt.
Robin Willcourt is a Family Medicine provider in Irvine, California. Dr. Willcourt and is rated as an Experienced provider by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. His top areas of expertise are Otitis, Tracheitis, Thrush, and Sinusitis.
The outcome varies. The disorder may continue long term, or you may have repeated episodes of symptoms. Complete recovery is possible, but permanent loss of nerve function is not uncommon.
Complications of CIDP include:
- Pain
- Permanent decrease or loss of sensation in areas of the body
- Permanent weakness or paralysis in areas of the body
- Repeated or unnoticed injury to an area of the body
- Side effects of medicines used to treat the disorder
Contact your provider if you have a loss of movement or sensation in any area of the body, especially if your symptoms get worse.
Summary: The purpose of the study is to evaluate efficacy of riliprubart compared to IVIg in adult participants with CIDP who are receiving maintenance treatment with IVIg. The study duration will be for a maximum of 109 weeks including screening, treatment phases, and follow-up.
Summary: ActiCIDP is a monocentric academic study. Patients with Chronic inflammatory demyelinating polyradiculoneuritis may be included on a voluntary basis. The investigators plan to include a group of approximately 40 patients with CIDP. The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily.
Published Date: June 13, 2024
Published By: Joseph V. Campellone, MD, Department of Neurology, Cooper Medical School at Rowan University, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Katirji B. Disorders of peripheral nerves. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 106.
Smith AG, Shy ME. Peripheral neuropathies. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 388.